Patent holdings for IPC class C07D 257/04

Total number of patents in this class: 1113

10-year publication summary

92
72
65
67
71
68
57
56
42
31
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Sumitomo Chemical Company, Limited
9109
36
Theravance Biopharma R&D IP, LLC
453
26
Novartis AG
10612
21
Bristol-myers Squibb Company
4826
18
Allergan, Inc.
2313
17
SK Biopharmaceuticals Co., Ltd.
269
13
Nippon Soda Co., Ltd.
892
12
Rigel Pharmaceuticals, Inc.
530
11
Viamet Pharmaceuticals, Inc.
37
11
F. Hoffmann-La Roche AG
7937
10
Bayer Cropscience AG
1983
10
Global Blood Therapeutics, Inc.
183
10
Zhejiang Huahai Pharmaceutical Co., Ltd.
211
10
Reata Pharmaceuticals, Inc.
118
9
Bayer Pharma AG
1048
8
Board of Regents, The University of Texas System
5946
8
Pacific Scientific Energetic Materials Company
49
8
Neurosearch A/S
169
8
Grey Wolf Therapeutics Limited
16
8
The Regents of the University of California
20303
7
Other owners 852